Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002235610 | SCV001043170 | likely benign | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390884 | SCV002703651 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-02-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000898933 | SCV001464444 | uncertain significance | Classic homocystinuria | 2020-08-13 | no assertion criteria provided | clinical testing |